APELLIS PHARMACEUTICALS INC (APLS) Stock Earnings & Estimates
NASDAQ:APLS - US03753U1060 - Common Stock
28.04 USD
+0.11 (+0.39%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 75.4M 13.21% | 396.591M 425.98% | 781.367M 97.02% | 942.23M 20.59% | 922.96M -2.05% | 1.125B 21.89% | 1.345B 19.56% | 1.568B 16.58% | 1.787B 13.97% | 1.951B 9.18% | 2.112B 8.25% | |
| EBITDA YoY % growth | -593.05M -10.87% | -515.337M 13.10% | -163.182M 68.33% | -103.675M 36.47% | 89.141M 185.98% | 245.05M 174.90% | 319.8M 30.50% | 467.93M 46.32% | 756.74M 61.72% | 856.95M 13.24% | 1.142B 33.26% | |
| EBIT YoY % growth | -594.6M -10.87% | -517.121M 13.03% | -164.979M 68.10% | -136.579M 17.21% | -77.139M 43.52% | 83.86M 208.71% | 234.22M 179.30% | 393.32M 67.93% | 575.08M 46.21% | 753.69M 31.06% | 872.61M 15.78% | |
| Operating Margin | -788.59% | -130.39% | -21.11% | -14.50% | -8.36% | 7.45% | 17.41% | 25.08% | 32.18% | 38.63% | 41.32% | |
| EPS YoY % growth | -6.13 31.35% | -4.48 26.92% | -1.45 67.63% | -0.79 45.53% | -0.93 -18.34% | 0.37 139.13% | 1.23 235.42% | 2.29 86.83% | 3.50 52.70% | 4.02 14.87% | 4.76 18.33% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.53 214.20% | -0.31 -6.06% | -0.48 35.52% | -0.35 -5.78% | -0.27 -150.49% | -0.14 55.64% | -0.09 80.76% | 0.21 161.36% | 0.33 223.08% | 0.46 436.45% |
| Revenue Q2Q % growth | 361.34M 83.58% | 218.37M 2.75% | 209.4M 25.54% | 221.49M 24.09% | 239.42M -33.74% | 263.38M 20.61% | 265.4M 26.74% | 310.3M 40.10% | 330.68M 38.12% | 357.6M 35.77% |
| EBITDA Q2Q % growth | 84.095M 283.09% | -21.564M 11.50% | -30.977M 62.62% | -49.195M -51.86% | -45.268M -153.83% | -2.009M 90.68% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 99.623M 310.71% | -35.735M -36.58% | -50.255M 39.69% | -43.31M -30.12% | -34.653M -134.78% | -12.798M 64.19% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.33 -17.86% | -0.49 | 0.16 | 32.75% |
| Q1 2025 Q2Q % growth | -0.74 -76.19% | -0.37 | -0.37 | -101.36% |
| Q4 2024 Q2Q % growth | -0.29 60.27% | -0.39 | 0.10 | 26.26% |
| Q3 2024 Q2Q % growth | -0.46 60.68% | -0.31 | -0.15 | -50.27% |
| Q2 2024 Q2Q % growth | -0.28 72.55% | -0.33 | 0.05 | 15.16% |
| Q1 2024 Q2Q % growth | -0.42 73.08% | -0.48 | 0.06 | 11.77% |
| Q4 2023 Q2Q % growth | -0.73 51.33% | -0.70 | -0.03 | -4.28% |
| Q3 2023 Q2Q % growth | -1.17 33.14% | -0.87 | -0.30 | -34.09% |
| Q2 2023 Q2Q % growth | -1.02 30.14% | -1.35 | 0.33 | 24.40% |
| Q1 2023 Q2Q % growth | -1.56 -9.86% | -1.49 | -0.07 | -4.46% |
| Q4 2022 Q2Q % growth | -1.50 6.83% | -1.60 | 0.10 | 6.20% |
| Q3 2022 Q2Q % growth | -1.75 23.25% | -1.48 | -0.27 | -17.99% |
| Q2 2022 Q2Q % growth | -1.46 46.32% | -1.39 | -0.07 | -4.87% |
| Q1 2022 Q2Q % growth | -1.42 38.79% | -1.35 | -0.07 | -5.49% |
| Q4 2021 Q2Q % growth | -1.61 -273.12% | -1.57 | -0.04 | -2.63% |
| Q3 2021 Q2Q % growth | -2.28 -27.37% | -1.73 | -0.55 | -31.79% |
| Q2 2021 Q2Q % growth | -2.72 -73.25% | -1.72 | -1.00 | -58.19% |
| Q1 2021 Q2Q % growth | -2.32 -1.31% | -1.62 | -0.70 | -43.34% |
| Q4 2020 Q2Q % growth | 0.93 152.54% | -0.77 | 1.70 | 221.15% |
| Q3 2020 Q2Q % growth | -1.79 -62.73% | -1.61 | -0.18 | -11.07% |
| Q2 2020 Q2Q % growth | -1.57 -40.18% | -1.36 | -0.21 | -15.26% |
| Q1 2020 Q2Q % growth | -2.29 -163.22% | -1.41 | -0.88 | -62.50% |
| Q4 2019 Q2Q % growth | -1.77 | -1.16 | -0.61 | -52.18% |
| Q3 2019 Q2Q % growth | -1.10 | -1.03 | -0.07 | -6.56% |
| Q2 2019 Q2Q % growth | -1.12 | -0.79 | -0.33 | -42.20% |
| Q1 2019 Q2Q % growth | -0.87 | -0.68 | -0.19 | -27.65% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 178.494M -10.61% | 192.29M | -13.796M | -7.17% |
| Q1 2025 Q2Q % growth | 166.797M -3.21% | 199.52M | -32.723M | -16.40% |
| Q4 2024 Q2Q % growth | 212.528M 45.19% | 202.32M | 10.208M | 5.05% |
| Q3 2024 Q2Q % growth | 196.83M 78.29% | 204.36M | -7.53M | -3.68% |
| Q2 2024 Q2Q % growth | 199.685M 110.26% | 194.9M | 4.785M | 2.46% |
| Q1 2024 Q2Q % growth | 172.325M 284.26% | 166.62M | 5.705M | 3.42% |
| Q4 2023 Q2Q % growth | 146.377M 544.83% | 146.47M | -93K | -0.06% |
| Q3 2023 Q2Q % growth | 110.399M 399.54% | 101.04M | 9.359M | 9.26% |
| Q2 2023 Q2Q % growth | 94.969M 482.63% | 71.657M | 23.312M | 32.53% |
| Q1 2023 Q2Q % growth | 44.846M 211.43% | 26.625M | 18.221M | 68.44% |
| Q4 2022 Q2Q % growth | 22.7M -62.35% | 24.921M | -2.221M | -8.91% |
| Q3 2022 Q2Q % growth | 22.1M 287.72% | 22.025M | 75K | 0.34% |
| Q2 2022 Q2Q % growth | 16.3M 2,616.67% | 17.283M | -983K | -5.69% |
| Q1 2022 Q2Q % growth | 14.4M | 12.824M | 1.576M | 12.29% |
| Q4 2021 Q2Q % growth | 60.3M -75.88% | 8.96M | 51.34M | 572.99% |
| Q3 2021 Q2Q % growth | 5.7M 850.00% | 7.37M | -1.67M | -22.66% |
| Q2 2021 Q2Q % growth | 600K | 509.918K | 90.082K | 17.67% |
| Q1 2021 Q2Q % growth | 2.318M | -2.318M | -100.00% | |
| Q4 2020 Q2Q % growth | 250M | 98.008M | 151.992M | 155.08% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 11268.7% | 283.49% | 55.14% | 59.34% |
| Revenue | 37.65% | 64.33% | 11.66% | 18.76% |